Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically.

Chafe SC, McDonald PC, Saberi S, Nemirovsky O, Venkateswaran G, Burugu S, Gao D, Delaidelli A, Kyle AH, Baker JHE, Gillespie JA, Bashashati A, Minchinton AI, Zhou Y, Shah SP, Dedhar S.

Cancer Immunol Res. 2019 Jul;7(7):1064-1078. doi: 10.1158/2326-6066.CIR-18-0657. Epub 2019 May 14.

PMID:
31088846
2.

Endothelial Sash1 Is Required for Lung Maturation through Nitric Oxide Signaling.

Coulombe P, Paliouras GN, Clayton A, Hussainkhel A, Fuller M, Jovanovic V, Dauphinee S, Umlandt P, Xiang P, Kyle AH, Minchinton AI, Humphries RK, Hoodless PA, Parker JDK, Wright JL, Karsan A.

Cell Rep. 2019 May 7;27(6):1769-1780.e4. doi: 10.1016/j.celrep.2019.04.039.

3.

Peggy Louise Olive.

Bennewith KL, Hill RP, Minchinton AI.

Radiat Res. 2019 Apr;191(4):380-381. No abstract available.

PMID:
30958759
4.

Fast and sensitive dynamic oxygen-enhanced MRI with a cycling gas challenge and independent component analysis.

Moosvi F, Baker JHE, Yung A, Kozlowski P, Minchinton AI, Reinsberg SA.

Magn Reson Med. 2019 Apr;81(4):2514-2525. doi: 10.1002/mrm.27584. Epub 2018 Oct 28.

PMID:
30368892
5.

Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment.

Baker JHE, Kyle AH, Reinsberg SA, Moosvi F, Patrick HM, Cran J, Saatchi K, Häfeli U, Minchinton AI.

Clin Exp Metastasis. 2018 Oct;35(7):691-705. doi: 10.1007/s10585-018-9929-3. Epub 2018 Sep 8.

6.

Identification of breast cancer cell subtypes sensitive to ATG4B inhibition.

Bortnik S, Choutka C, Horlings HM, Leung S, Baker JH, Lebovitz C, Dragowska WH, Go NE, Bally MB, Minchinton AI, Gelmon KA, Gorski SM.

Oncotarget. 2016 Oct 11;7(41):66970-66988. doi: 10.18632/oncotarget.11408.

7.

The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growth.

Yapp DT, Wong MQ, Kyle AH, Valdez SM, Tso J, Yung A, Kozlowski P, Owen DA, Buczkowski AK, Chung SW, Scudamore CH, Minchinton AI, Ng SS.

Angiogenesis. 2016 Apr;19(2):229-44. doi: 10.1007/s10456-016-9503-z. Epub 2016 Mar 9.

8.

Tissue Discs: A 3D Model for Assessing Modulation of Tissue Oxygenation.

Gandolfo MJ, Kyle AH, Minchinton AI.

Adv Exp Med Biol. 2016;876:169-175. doi: 10.1007/978-1-4939-3023-4_21.

PMID:
26782209
9.

Multi-modal magnetic resonance imaging and histology of vascular function in xenografts using macromolecular contrast agent hyperbranched polyglycerol (HPG-GdF).

Baker JH, McPhee KC, Moosvi F, Saatchi K, Häfeli UO, Minchinton AI, Reinsberg SA.

Contrast Media Mol Imaging. 2016 Jan-Feb;11(1):77-88. doi: 10.1002/cmmi.1661. Epub 2015 Aug 13.

PMID:
26268906
10.

Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis.

El-Naggar AM, Veinotte CJ, Cheng H, Grunewald TG, Negri GL, Somasekharan SP, Corkery DP, Tirode F, Mathers J, Khan D, Kyle AH, Baker JH, LePard NE, McKinney S, Hajee S, Bosiljcic M, Leprivier G, Tognon CE, Minchinton AI, Bennewith KL, Delattre O, Wang Y, Dellaire G, Berman JN, Sorensen PH.

Cancer Cell. 2015 May 11;27(5):682-97. doi: 10.1016/j.ccell.2015.04.003.

11.

The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association.

Kridel R, Xerri L, Gelas-Dore B, Tan K, Feugier P, Vawda A, Canioni D, Farinha P, Boussetta S, Moccia AA, Brice P, Chavez EA, Kyle AH, Scott DW, Sanders AD, Fabiani B, Slack GW, Minchinton AI, Haioun C, Connors JM, Sehn LH, Steidl C, Gascoyne RD, Salles G.

Clin Cancer Res. 2015 Aug 1;21(15):3428-35. doi: 10.1158/1078-0432.CCR-14-3253. Epub 2015 Apr 13.

12.

Loss of the Notch effector RBPJ promotes tumorigenesis.

Kulic I, Robertson G, Chang L, Baker JH, Lockwood WW, Mok W, Fuller M, Fournier M, Wong N, Chou V, Robinson MD, Chun HJ, Gilks B, Kempkes B, Thomson TA, Hirst M, Minchinton AI, Lam WL, Jones S, Marra M, Karsan A.

J Exp Med. 2015 Jan 12;212(1):37-52. doi: 10.1084/jem.20121192. Epub 2014 Dec 15.

13.

Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models.

Sørensen BS, Busk M, Horsman MR, Alsner J, Overgaard J, Kyle AH, Minchinton AI.

Anticancer Res. 2014 Nov;34(11):6297-304.

PMID:
25368228
14.

Tissue penetration and activity of camptothecins in solid tumor xenografts.

Kyle AH, Baker JH, Gandolfo MJ, Reinsberg SA, Minchinton AI.

Mol Cancer Ther. 2014 Nov;13(11):2727-37. doi: 10.1158/1535-7163.MCT-14-0475. Epub 2014 Aug 20.

15.

Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism.

Patenaude A, Fuller M, Chang L, Wong F, Paliouras G, Shaw R, Kyle AH, Umlandt P, Baker JH, Diaz E, Tong J, Minchinton AI, Karsan A.

Cancer Res. 2014 May 1;74(9):2402-11. doi: 10.1158/0008-5472.CAN-12-4038. Epub 2014 Mar 5.

16.

Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin.

Baker JH, Kyle AH, Bartels KL, Methot SP, Flanagan EJ, Balbirnie A, Cran JD, Minchinton AI.

PLoS One. 2013 Oct 28;8(10):e76832. doi: 10.1371/journal.pone.0076832. eCollection 2013.

17.

Radiobiological effects of altering dose rate in filter-free photon beams.

Karan T, Moiseenko V, Gill B, Horwood R, Kyle A, Minchinton AI.

Phys Med Biol. 2013 Feb 21;58(4):1075-82. doi: 10.1088/0031-9155/58/4/1075. Epub 2013 Jan 31.

PMID:
23363688
18.

Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.

Daly C, Eichten A, Castanaro C, Pasnikowski E, Adler A, Lalani AS, Papadopoulos N, Kyle AH, Minchinton AI, Yancopoulos GD, Thurston G.

Cancer Res. 2013 Jan 1;73(1):108-18. doi: 10.1158/0008-5472.CAN-12-2064. Epub 2012 Nov 13.

19.

Differentiation of vascular smooth muscle cells from local precursors during embryonic and adult arteriogenesis requires Notch signaling.

Chang L, Noseda M, Higginson M, Ly M, Patenaude A, Fuller M, Kyle AH, Minchinton AI, Puri MC, Dumont DJ, Karsan A.

Proc Natl Acad Sci U S A. 2012 May 1;109(18):6993-8. doi: 10.1073/pnas.1118512109. Epub 2012 Apr 16.

20.

Effects of tirapazamine on experimental colorectal liver metastases after radiofrequency ablation.

Govaert KM, Nijkamp MW, Emmink BL, Steller EJ, Minchinton AI, Kranenburg O, Borel Rinkes IH.

Br J Surg. 2012 Apr;99(4):567-75. doi: 10.1002/bjs.8668. Epub 2012 Feb 13.

PMID:
22331808
21.

Targeting quiescent tumor cells via oxygen and IGF-I supplementation.

Kyle AH, Baker JH, Minchinton AI.

Cancer Res. 2012 Feb 1;72(3):801-9. doi: 10.1158/0008-5472.CAN-11-3059. Epub 2011 Dec 12.

22.

Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium.

Mugabe C, Raven PA, Fazli L, Baker JH, Jackson JK, Liggins RT, So AI, Gleave ME, Minchinton AI, Brooks DE, Burt HM.

Biomaterials. 2012 Jan;33(2):692-703. doi: 10.1016/j.biomaterials.2011.09.081. Epub 2011 Oct 19.

PMID:
22014457
23.

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity.

Dragowska WH, Weppler SA, Qadir MA, Wong LY, Franssen Y, Baker JH, Kapanen AI, Kierkels GJ, Masin D, Minchinton AI, Gelmon KA, Bally MB.

BMC Cancer. 2011 Oct 1;11:420. doi: 10.1186/1471-2407-11-420.

24.

A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation.

Ho VW, Leung K, Hsu A, Luk B, Lai J, Shen SY, Minchinton AI, Waterhouse D, Bally MB, Lin W, Nelson BH, Sly LM, Krystal G.

Cancer Res. 2011 Jul 1;71(13):4484-93. doi: 10.1158/0008-5472.CAN-10-3973. Epub 2011 Jun 14.

25.

Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration.

Maltby S, Freeman S, Gold MJ, Baker JH, Minchinton AI, Gold MR, Roskelley CD, McNagny KM.

PLoS One. 2011 Apr 11;6(4):e18160. doi: 10.1371/journal.pone.0018160.

26.

In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancer.

Mugabe C, Matsui Y, So AI, Gleave ME, Baker JH, Minchinton AI, Manisali I, Liggins R, Brooks DE, Burt HM.

Clin Cancer Res. 2011 May 1;17(9):2788-98. doi: 10.1158/1078-0432.CCR-10-2981. Epub 2011 Feb 28.

27.

Vascularization predicts overall survival and risk of transformation in follicular lymphoma.

Farinha P, Kyle AH, Minchinton AI, Connors JM, Karsan A, Gascoyne RD.

Haematologica. 2010 Dec;95(12):2157-60. doi: 10.3324/haematol.2009.021766. Epub 2010 Aug 16.

28.

Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma.

Cham KK, Baker JH, Takhar KS, Flexman JA, Wong MQ, Owen DA, Yung A, Kozlowski P, Reinsberg SA, Chu EM, Chang CW, Buczkowski AK, Chung SW, Scudamore CH, Minchinton AI, Yapp DT, Ng SS.

Br J Cancer. 2010 Jun 29;103(1):52-60. doi: 10.1038/sj.bjc.6605727. Epub 2010 Jun 8.

29.

Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging.

Bains LJ, Baker JH, Kyle AH, Minchinton AI, Reinsberg SA.

Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):957-65. doi: 10.1016/j.ijrobp.2008.11.068.

PMID:
19480975
30.

Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin.

Baker JH, Lam J, Kyle AH, Sy J, Oliver T, Co SJ, Dragowska WH, Ramsay E, Anantha M, Ruth TJ, Adam MJ, Yung A, Kozlowski P, Minchinton AI, Ng SS, Bally MB, Yapp DT.

Clin Cancer Res. 2008 Nov 15;14(22):7260-71. doi: 10.1158/1078-0432.CCR-08-0736.

31.

Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts.

Baker JH, Lindquist KE, Huxham LA, Kyle AH, Sy JT, Minchinton AI.

Clin Cancer Res. 2008 Apr 1;14(7):2171-9. doi: 10.1158/1078-0432.CCR-07-4465. Erratum in: Clin Cancer Res. 2008 May 1;14(9):2893.

32.

Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK).

Edwards LA, Woo J, Huxham LA, Verreault M, Dragowska WH, Chiu G, Rajput A, Kyle AH, Kalra J, Yapp D, Yan H, Minchinton AI, Huntsman D, Daynard T, Waterhouse DN, Thiessen B, Dedhar S, Bally MB.

Mol Cancer Ther. 2008 Jan;7(1):59-70. doi: 10.1158/1535-7163.MCT-07-0329.

33.

Exploring vascular dysfunction caused by tirapazamine.

Huxham LA, Kyle AH, Baker JH, McNicol KL, Minchinton AI.

Microvasc Res. 2008 Mar;75(2):247-55. Epub 2007 Oct 11.

PMID:
18023823
34.

The impact of complement activation on tumor oxygenation during photodynamic therapy.

Cecic I, Minchinton AI, Korbelik M.

Photochem Photobiol. 2007 Sep-Oct;83(5):1049-55.

PMID:
17880499
35.

Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors.

Kyle AH, Huxham LA, Yeoman DM, Minchinton AI.

Clin Cancer Res. 2007 May 1;13(9):2804-10.

36.

Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin.

Dragowska WH, Verreault M, Yapp DT, Warburton C, Edwards L, Ramsay EC, Huxham LA, Minchinton AI, Gelmon K, Bally MB.

Breast Cancer Res Treat. 2007 Dec;106(3):319-31. Epub 2007 Mar 9.

PMID:
17347776
37.

Drug penetration in solid tumours.

Minchinton AI, Tannock IF.

Nat Rev Cancer. 2006 Aug;6(8):583-92. Review.

PMID:
16862189
38.

Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay.

Baker JH, Huxham LA, Kyle AH, Lam KK, Minchinton AI.

Microvasc Res. 2006 Mar;71(2):69-75. Epub 2006 Mar 20.

PMID:
16545400
39.

Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts.

Huxham LA, Kyle AH, Baker JH, McNicol KL, Minchinton AI.

Radiother Oncol. 2006 Feb;78(2):138-45. Epub 2006 Feb 7.

PMID:
16455148
40.

SHIP represses the generation of alternatively activated macrophages.

Rauh MJ, Ho V, Pereira C, Sham A, Sly LM, Lam V, Huxham L, Minchinton AI, Mui A, Krystal G.

Immunity. 2005 Oct;23(4):361-74.

41.

HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.

Dragowska WH, Warburton C, Yapp DT, Minchinton AI, Hu Y, Waterhouse DN, Gelmon K, Skov K, Woo J, Masin D, Huxham LA, Kyle AH, Bally MB.

Mol Cancer Res. 2004 Nov;2(11):606-19.

42.

Microregional effects of gemcitabine in HCT-116 xenografts.

Huxham LA, Kyle AH, Baker JH, Nykilchuk LK, Minchinton AI.

Cancer Res. 2004 Sep 15;64(18):6537-41.

43.

Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture.

Kyle AH, Huxham LA, Chiam AS, Sim DH, Minchinton AI.

Cancer Res. 2004 Sep 1;64(17):6304-9.

44.

The effect of deep inspiration breath-hold on tumour oxygenation.

Aquino-Parsons C, Ries CR, Minchinton AI, D'yachkova Y.

Clin Oncol (R Coll Radiol). 2003 Oct;15(7):386-93.

PMID:
14570086
45.

Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent.

Kyle AH, Huxham LA, Baker JH, Burston HE, Minchinton AI.

Cancer Res. 2003 Sep 15;63(18):5707-11.

46.

Carbogen breathing after irradiation enhances the effectiveness of tirapazamine in SiHa tumors but not SCCVII tumors in mice.

Minchinton AI, Tonn DA, Sutherland DP, Kyle AH.

Radiat Res. 2002 Jul;158(1):94-100.

PMID:
12071808
47.

Oxygen tension in primary gynaecological tumours: the influence of carbon dioxide concentration.

Aquino-Parsons C, Green A, Minchinton AI.

Radiother Oncol. 2000 Oct;57(1):45-51. Erratum in: Radiother Oncol 2001 Apr;59(1):109-10.

PMID:
11033188
48.

Effect of breathing carbogen on the oxygen tension of murine and human tumours measured using an Eppendorf pO2 histograph.

Minchinton AI, Fryer KH, Lim P, Aquino-Parsons C.

Adv Exp Med Biol. 1999;471:507-13. No abstract available.

PMID:
10659184
49.

Carbogen inhalation in cervical cancer: assessment of oxygenation change.

Aquino-Parsons C, Lim P, Green A, Minchinton AI.

Gynecol Oncol. 1999 Aug;74(2):259-64.

PMID:
10419742
50.

Supplemental Content

Loading ...
Support Center